FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2997234051> ?p ?o ?g. }

• W2997234051 endingPage "1761" @default.
• W2997234051 startingPage "1753" @default.
• W2997234051 abstract "We have earlier reported that a single dose of oral cholera vaccine (OCV) is protective in adults and children ≥5 years of age and sustained for 2 years. We enrolled participants (n = 240) from this study, between March-September 2017, over 3 years after receiving a primary single dose. Immune responses were measured in placebo group (Primary Immunization group: PI) and compared with those who received a single dose (Booster Immunization group: BI). The children were 4 to <5 years, 5 to <18 years and adults >18 years. Blood was collected at day 0 (before vaccination) and after receiving 1st and 2nd doses of OCV. Overall, the BI and PI groups showed vibriocidal antibody response after 1st and 2nd dose of vaccination in all age groups to V. cholerae O1 and O139. Young children in the BI group showed significantly higher vibriocidal antibody response two weeks after receiving the first dose as compared to PI group to LPS. Elevated plasma IgA responses to LPS after the first dose were observed among the BI group compared to the PI group among the young children. Mucosal antibody responses measured in fecal extracts showed similar increases as that of vibriocidal and LPS responses in the BI group. These results suggest a single boosting dose of OCV generated immune response in primed population >5 years of age who had earlier received OCV. However, young children who had received OCV earlier, boosting after a single dose, resulted in increased immune responses compared to the PI group. Further studies are needed to assess protection obtained from different strategies, especially for young children and to determine the numbers of primary and booster doses needed. In addition, more information is needed regarding the optimum interval between primary and booster doses to plan future interventions for cholera control. ClinicalTrials.gov Identifier: NCT 02027207." @default.
• W2997234051 created "2020-01-10" @default.
• W2997234051 creator A5001108158 @default.
• W2997234051 creator A5006065422 @default.
• W2997234051 creator A5006107625 @default.
• W2997234051 creator A5014441581 @default.
• W2997234051 creator A5021173085 @default.
• W2997234051 creator A5033233030 @default.
• W2997234051 creator A5033554066 @default.
• W2997234051 creator A5038323926 @default.
• W2997234051 creator A5039080326 @default.
• W2997234051 creator A5039650840 @default.
• W2997234051 creator A5041318439 @default.
• W2997234051 creator A5044946797 @default.
• W2997234051 creator A5047420332 @default.
• W2997234051 creator A5049207975 @default.
• W2997234051 creator A5071390832 @default.
• W2997234051 creator A5079891198 @default.
• W2997234051 creator A5090951645 @default.
• W2997234051 date "2020-02-01" @default.
• W2997234051 modified "2023-10-18" @default.
• W2997234051 title "Augmented immune responses to a booster dose of oral cholera vaccine in Bangladeshi children less than 5 years of age: Revaccination after an interval of over three years of primary vaccination with a single dose of vaccine" @default.
• W2997234051 cites W1897470778 @default.
• W2997234051 cites W2011928313 @default.
• W2997234051 cites W2033634893 @default.
• W2997234051 cites W2042970602 @default.
• W2997234051 cites W2057884583 @default.
• W2997234051 cites W2061826617 @default.
• W2997234051 cites W2078861301 @default.
• W2997234051 cites W2082011551 @default.
• W2997234051 cites W2097466208 @default.
• W2997234051 cites W2116640983 @default.
• W2997234051 cites W2126103198 @default.
• W2997234051 cites W2126901488 @default.
• W2997234051 cites W2130957436 @default.
• W2997234051 cites W2131609674 @default.
• W2997234051 cites W2137904184 @default.
• W2997234051 cites W2139227638 @default.
• W2997234051 cites W2166559731 @default.
• W2997234051 cites W2166635834 @default.
• W2997234051 cites W2166880878 @default.
• W2997234051 cites W2167632261 @default.
• W2997234051 cites W2307019207 @default.
• W2997234051 cites W2345648153 @default.
• W2997234051 cites W2560160864 @default.
• W2997234051 cites W2694699743 @default.
• W2997234051 cites W2736003652 @default.
• W2997234051 cites W2789456736 @default.
• W2997234051 cites W2800601437 @default.
• W2997234051 cites W2888054208 @default.
• W2997234051 cites W4210745748 @default.
• W2997234051 cites W4210949416 @default.
• W2997234051 doi "https://doi.org/10.1016/j.vaccine.2019.12.034" @default.
• W2997234051 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7014297" @default.
• W2997234051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31879124" @default.
• W2997234051 hasPublicationYear "2020" @default.
• W2997234051 type Work @default.
• W2997234051 sameAs 2997234051 @default.
• W2997234051 citedByCount "7" @default.
• W2997234051 countsByYear W29972340512021 @default.
• W2997234051 countsByYear W29972340512022 @default.
• W2997234051 countsByYear W29972340512023 @default.
• W2997234051 crossrefType "journal-article" @default.
• W2997234051 hasAuthorship W2997234051A5001108158 @default.
• W2997234051 hasAuthorship W2997234051A5006065422 @default.
• W2997234051 hasAuthorship W2997234051A5006107625 @default.
• W2997234051 hasAuthorship W2997234051A5014441581 @default.
• W2997234051 hasAuthorship W2997234051A5021173085 @default.
• W2997234051 hasAuthorship W2997234051A5033233030 @default.
• W2997234051 hasAuthorship W2997234051A5033554066 @default.
• W2997234051 hasAuthorship W2997234051A5038323926 @default.
• W2997234051 hasAuthorship W2997234051A5039080326 @default.
• W2997234051 hasAuthorship W2997234051A5039650840 @default.
• W2997234051 hasAuthorship W2997234051A5041318439 @default.
• W2997234051 hasAuthorship W2997234051A5044946797 @default.
• W2997234051 hasAuthorship W2997234051A5047420332 @default.
• W2997234051 hasAuthorship W2997234051A5049207975 @default.
• W2997234051 hasAuthorship W2997234051A5071390832 @default.
• W2997234051 hasAuthorship W2997234051A5079891198 @default.
• W2997234051 hasAuthorship W2997234051A5090951645 @default.
• W2997234051 hasBestOaLocation W29972340511 @default.
• W2997234051 hasConcept C12590561 @default.
• W2997234051 hasConcept C126322002 @default.
• W2997234051 hasConcept C203014093 @default.
• W2997234051 hasConcept C22070199 @default.
• W2997234051 hasConcept C2777047711 @default.
• W2997234051 hasConcept C2778643871 @default.
• W2997234051 hasConcept C2780801004 @default.
• W2997234051 hasConcept C2908647359 @default.
• W2997234051 hasConcept C523546767 @default.
• W2997234051 hasConcept C54355233 @default.
• W2997234051 hasConcept C71924100 @default.
• W2997234051 hasConcept C86803240 @default.
• W2997234051 hasConcept C8891405 @default.
• W2997234051 hasConcept C99454951 @default.
• W2997234051 hasConceptScore W2997234051C12590561 @default.
• W2997234051 hasConceptScore W2997234051C126322002 @default.
• W2997234051 hasConceptScore W2997234051C203014093 @default.

• next